Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

516 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Residual thrombosis on ultrasonography to guide the duration of anticoagulation in patients with deep venous thrombosis: a randomized trial.
Prandoni P, Prins MH, Lensing AW, Ghirarduzzi A, Ageno W, Imberti D, Scannapieco G, Ambrosio GB, Pesavento R, Cuppini S, Quintavalla R, Agnelli G; AESOPUS Investigators. Prandoni P, et al. Ann Intern Med. 2009 May 5;150(9):577-85. doi: 10.7326/0003-4819-150-9-200905050-00003. Ann Intern Med. 2009. PMID: 19414836 Free article. Clinical Trial.
Thrombotic risk and features of patients with inferior vena cava agenesis: a multicentre, retrospective, observational study.
Bravo-Pérez C, Blanco A, Revilla N, Cobos J, Salgado-Parente A, Asenjo S, Méndez R, Marti-Bonmati L, Bonanad S, Albillos JC, Castro N, Marcellini S, López Sala P, Lasa M, Bastida JM, Infante MS, Corral MA, Pagan J, Llamas P, Rodríguez-Sevilla JJ, Rodríguez-Alen A, Sevivas TS, Morello D, Villar CG, Lojo S, Marco A, Simioni P, Vicente V, Lozano ML, de la Morena-Barrio ME, García-Santos JM, Corral J; IVC Agenesis Study Group. Bravo-Pérez C, et al. Among authors: simioni p. Lancet Haematol. 2024 Aug;11(8):e606-e616. doi: 10.1016/S2352-3026(24)00138-8. Epub 2024 Jun 12. Lancet Haematol. 2024. PMID: 38878784
Clinical outcomes after discontinuing anticoagulant therapy in patients with first unprovoked venous thromboembolism.
Gabara C, Aibar J, Nishimoto Y, Yamashita Y, Prandoni P, Barnes GD, Bikdeli B, Jiménez D, Demelo-Rodríguez P, Peris ML, Nguyen ST, Monreal M; Registro Informatizado Enfermedad Trombo Embólica Investigators. Gabara C, et al. J Thromb Haemost. 2024 Aug;22(8):2234-2246. doi: 10.1016/j.jtha.2024.05.007. Epub 2024 May 16. J Thromb Haemost. 2024. PMID: 38762019
Bodyweight-adjusted rivaroxaban for children with venous thromboembolism (EINSTEIN-Jr): results from three multicentre, single-arm, phase 2 studies.
Monagle P, Lensing AWA, Thelen K, Martinelli I, Male C, Santamaría A, Samochatova E, Kumar R, Holzhauer S, Saracco P, Simioni P, Robertson J, Grangl G, Halton J, Connor P, Young G, Molinari AC, Nowak-Göttl U, Kenet G, Kapsa S, Willmann S, Pap AF, Becka M, Twomey T, Beyer-Westendorf J, Prins MH, Kubitza D; EINSTEIN-Jr Phase 2 Investigators. Monagle P, et al. Among authors: simioni p. Lancet Haematol. 2019 Oct;6(10):e500-e509. doi: 10.1016/S2352-3026(19)30161-9. Epub 2019 Aug 13. Lancet Haematol. 2019. PMID: 31420317 Clinical Trial.
516 results